Bowhead Specialty Holdings Inc. provides commercial specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions, including directors and officers liability, errors and omissions liability, employment practices liability, fiduciary liability, fidelity liability and miscellaneous professional liability, crime insurance, and cyber for financial institutions; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and management liability segments. In addition, it offers Baleen Specialty, a technology-powered underwriting operation, that specializes in small to mid-sized risks that are not eligible in the admitted market. It distributes its products through distribution partners in wholesale and retail markets. The company was formerly known as Bowhead Holdings Inc. and changed its name to Bowhead Specialty Holdings Inc. in March 2024. The company was founded in 2020 and is based in New York, New York.…
3 Insurance Stocks for Rising AI Risk in Cyber and Specialty Cover
Bowhead Specialty Holdings (NYSE: BOW) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Insurance - Property & Casualty industry, part of the Financial Services sector, and reports about 296 employees.
The shares were at 34.25 USD on 20 November 2026, up 27.8% over 52 weeks. Its 52-week range is 21.21 USD to 35.07 USD: the price is 2.3% below the high and 61.5% above the low.
At a market capitalisation of 1.13B USD, it trades at 19.4 times trailing earnings and 13.9 times forward earnings. The median trailing P/E of its 19 largest Insurance - Property & Casualty peers is 12.9, a premium of 50% for BOW.
Bowhead Specialty Holdings reports return on equity of 12.0%, an operating margin of 15.0% and revenue up 19.3% year over year.
It holds more cash than debt, a net cash position of 83.59M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Hold; their mean price target of 34.33 USD is 0.2% above the current price. The next earnings report is expected on 23 February 2027.